| Sharing Excellence |
| Video Clips |
| Book Reviews |
| News / Articles |

| HOME |
| ABOUT IDEA |
| STRATEGY AT PHASE II |
| MEASURING |
| SHARING |
| CONTACT IDEA |
| USEFUL LINKS |
| IDEA Junkie |
| IDEA Collider |
| | CLIENT AREA |
Watch Mike Rea explain Strategy at Phase II,
path-to-market
Strategy and Q2.
IDEA Pharma has launched the second annual Productive Innovation Index (PII), ranking 21 global phar..
For a closer look, go to: http://www.samedanltd.com/magazine/current/12 Lifecycle decisions are ..
For something that is supposed to be so clear, the terms used in Pharma strategy can cause confu..
With IDEA Pharma’s US operations securing an ever-stronger foothold, awareness is growing as t..
As IDEA Pharma widens its net across Europe, business is booming as the ‘IDEA house’..
As the ‘IDEA revolution’ continues to make waves within Pharma, more and more compan..
IDEA Pharma’s Principal IDEAtor, Mike Rea, has been voted among the PharmaVOICE Top 100 Mo..
The industry has a well-recognised problem. There is a prevailing view that developing drugs is ..
IDEA Pharma makes public its annual Productive Innovation Index (PII) With only one in four ..
IDEAtion is the process of building IDEAs. IDEAtion ensures the potential or the talent of a mol..
This is not an industry that does what is easy instead of what is best. This is not an industry ..
It used to be that those involved in the process of communication understood which part of the p..
Here’s the thing about Efficacy. It doesn’t exist. It is an abstract concept, a shorthan..
Cards on the table: no two ‘scenario planning’ projects are the same, or should be t..